Home | Non-food | Drug

Drug

Vascudilators linked to age-related macular degeneration

Wednesday May 28, 2014 (foodconsumer.org) -- Taking high blood pressure drugs vasodilators may increase risk of early-stage age-related macular degeneration (AMD), a study in the

Lupus Therapies Continue to Evolve (May is National Lupus Awareness Month)

It can be a difficult disease to diagnose and a difficult disease to treat. It’s called lupus, and as many as 24,000 people in the ...
Full story

FDA approves Dalvance to treat skin infections

The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. Dalvance is intended to treat ...
Full story

Hepatitis B Vaccine Approved

May 20, 2014 Approval Letter - Recombivax HB   Our STN: BL 101066/5591   Merck Sharp & Dohme Corp. Attention: Paul L. Koser, Ph.D.                                             P.O. Box 1000, UG2D-68 North Wales, PA 19454-1099   Dear Dr. Koser:   We ...
Full story

FDA Updates for Health Professionals

PRODUCT SAFETY Need Safety Information? For more important safety information on human drugs, medical devices, dietary supplements and more, please visit MedWatch. To receive MedWatch Safety Alerts by ...
Full story

Antisense oligonucleotide (OL-1) may cure Alzheimer's disease?

Wednesday May 21, 2014 (foodconsumer.org) -- A compound called Antisense oligonucleotide (OL-1) may reverse the symptoms of Alzheimer's disease, according to a study published in ...
Full story

Update of CVM's What's New - Get the Facts about Pain Relievers for Pets

Your 8-year-old yellow Lab Tinker Bell just came in from the backyard and you notice she’s limping on one of her back legs. You check ...
Full story

A drug used to treat idiopathic pulmonary fibrosis found ineffective

CONTACT: NHLBI Communications, 301-496-4236, <e-mail:NHLBI_news@nhlbi.nih.gov>COMMON TREATMENT FOR PATIENTS WITH CHRONIC, PROGRESSIVE LUNG DISEASE FOUND TO BE INEFFECTIVEA drug used to treat patients with mild to moderate ...
Full story

FDA requiring lower starting dose for sleep drug Lunesta

FDA NEWS RELEASE For Immediate Release: May 15, 2014Media Inquiries: Sandy Walsh, 301-796-4669, sandy.walsh@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA requiring lower starting dose for sleep drug Lunesta Risk of impairment the morning after use ...
Full story

Pradaxa (dabigatran): Drug Safety Communication - Lower Risk for Stroke and Death, but Higher Risk for GI Bleeding Compared to Warfarin

Pradaxa (dabigatran): Drug Safety Communication - Lower Risk for Stroke and Death, but Higher Risk for GI Bleeding Compared to Warfarin     AUDIENCE: Cardiology, Patient, Pulmonology, Internal ...
Full story
back 1 2 3 4 5 6 7 8 9 10 next last total: 1040 | displaying: 81 - 90